Short-term Effectiveness and Safety of Rituximab Versus Cyclophosphamide for Life-Threatening ANCA-associated Vasculitis: a Propensity Score Analysis of the Real-World Nationwide Database.
ANNALS OF THE RHEUMATIC DISEASES（2024）
Key words
rituximab,cyclophosphamide,systemic vasculitis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined